课题基金 / 基金详情

Measuring Incident Human Immonodeficiency Virus (HIV-1) Infections in China

Measuring Incident Human Immonodeficiency Virus (HIV-1) Infections in China
测量中国人类免疫缺陷病毒 (HIV-1) 感染事件
批准号:
7455810
负责人:
STEN H. VERMUND
金额:
$6.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2010-06-30

项目摘要

项目成果

STEN H. VERMUND的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): China has 1.3 billion people, accounting for 20% of the world's population. Even a slight increase in the infection rate of human immunodeficiency virus type 1 (HIV-1) would result in a substantial increase in the absolute number of infected persons. While it is clear from seroprevalence data that HIV is spreading from high risk groups to the general population, Chinese health authorities have no effective measures for HIV incidence. HIV prevalence provides a good picture of the history of the epidemic, but does not highlight recent trends or "hotspots". HIV incidence surveillance (HIS) is needed to distinguish between recent and long-term HIV infection, to determinate patterns of infection in high-risk populations, to facilitate time-sensitive evaluation of HIV transmission dynamics, to pinpoint outbreaks, and to measure the effectiveness of prevention programs. The objective of our proposed study is to validate a novel serologic method--- an immunoglobulin G (IgG)- capture types B, E, and D ("BED")-enzyme immunoassay (BED-CEIA) to identify recent HIV-1 seroconversion --- to measure HIV incidence in China. We will assess the validity and feasibility of developing a serology based HIS to provide more accurate information for public health intervention, resource distribution, and program evaluation. The Specific Aims of This Project are: 1). To assess the validity of the BED -CEIA for measuring HIV-1 incidence by studying well-characterized pre- and post-seroconversion specimens from Chinese participants in prospective cohorts. Year one of this R03 award is in the service of Specific Aim 1. 2). Either (OPTION 1) to begin the process of developing a China-specific BED-CEIA, or (OPTION 2) to plan a pilot HIS project using the validated BED-CEIA. Whether we pursue option 1 or 2 will depend upon the results of Specific Aim 1. Year two of this R03 award will be in the pursuit of option 1 or 2, as the science dictates.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
[Evaluation of BED-CEIA assay with dried blood spot specimens in China].
中国干血斑标本 BED-CEIA 检测的评价[J].
DOI: --
发表时间: 2009
期刊: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
影响因子: --
作者: [Shen,Sheng, Tian,Fei, Jiang,Hua-Zhou, Sun,Guo-Qing, Miao,Li-Feng, Guo,Xiao-Li, Xiao,Yao, Jia,Yu-Jiang, Vermund,StenH, Jiang,Yan]
通讯作者: Jiang,Yan
Continuum of Care
Expanded Testing, Linkage, and Treatment for HIV Prevention Among MSM in China
  • 批准号:
    8143063
  • 项目类别:
  • 资助金额:
    $22.65万
  • 财政年份:
    2011
  • 负责人:
    STEN H. VERMUND
  • 依托单位:
Multi-component HIV Intervention Packages for Chinese MSM
  • 批准号:
    8113122
  • 项目类别:
  • 资助金额:
    $55.77万
  • 财政年份:
    2011
  • 负责人:
    STEN H. VERMUND
  • 依托单位:
Multi-component HIV Intervention Packages for Chinese MSM
  • 批准号:
    8241895
  • 项目类别:
  • 资助金额:
    $85.15万
  • 财政年份:
    2011
  • 负责人:
    STEN H. VERMUND
  • 依托单位: